Ninth Annual Program Recognizes BostonGene’s Multimodal AI Infrastructure for Reducing Risk and Accelerating Oncology Drug DevelopmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, leading developer of ...